pharmaphorum
FEBRUARY 18, 2024
Around 1,000 people with Parkinson’s in England will be able to access treatment with AbbVie’s Produodopa, the first therapy delivered by a 24-hour subcutaneous infusion pump
Pharmacy Joe
FEBRUARY 18, 2024
In this episode, I’ll discuss whether ICU patients benefit from daily QTc interval monitoring during antipsychotic use for delirium. Episode 897: Is It Necessary To Monitor QTc of ICU Patients Receiving Antipsychotics for Delirium? Subscribe on iTunes , Android , or Stitcher QTc prolongation is a known side effect of antipsychotic use. While the QTc itself is only a number on a sheet of paper, a prolonged QTc is often used as a surrogate marker for an increased risk of torsades.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 18, 2024
Iovance Biotherapeutics has become the first company to win FDA approval for a cell therapy used to treat a solid tumour, Amtagvi for melanoma
Express Pharma
FEBRUARY 18, 2024
In a recent quarterly update, AstraZeneca revealed that it removed tozorakimab from its Phase II pipeline for diabetic kidney disease (DKD). The objective of the Phase IIb study was to evaluate the safety and efficacy of tozorakimab in subjects with DKD. Specifically, the Phase IIb trial was discontinued because of the efficacy data. Despite this setback, AstraZeneca is looking to differentiate in the DKD space with its pipeline drug, zibotentan.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Med Ed 101
FEBRUARY 18, 2024
The 2024 ADA guidelines were released a month or two ago and I wanted to take a little time to digest them before providing my big takeaways. The 2023 guidelines saw a major shift in pharmacotherapy with a strong emphasis on compelling indications and recommended increased utilization of GLP-1 Agonists and SGLT2 inhibitors. The 2024 […] The post 2024 ADA Guidelines – Free PDF and My Takeaways appeared first on Med Ed 101.
Drug Patent Watch
FEBRUARY 18, 2024
This chart shows the pharmaceutical companies with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
115 
Let's personalize your content